PPIs may raise risks for ventilated patients, study says

02/25/2014 | Medscape (free registration)

An observational study in JAMA Internal Medicine suggested proton pump inhibitor therapy for mechanically ventilated patients may raise the risk of gastrointestinal bleeding, pneumonia and Clostridium difficile infection, when compared with a histamine-2 receptor antagonist. The drugs are commonly used as a stress ulcer prophylaxis in ICU patients, and researchers said more studies are needed before recommending a change in practice.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC